Benzodiazepine Drugs Market Trends

Benzodiazepine Drugs Market Trends

• Increasing prevalence of anxiety disorders has emerged as a significant growth driver for the benzodiazepine drug market. Anxiety disorders, including generalized anxiety disorder, panic disorder, and social anxiety disorder, affect millions of individuals worldwide, leading to a substantial burden on healthcare systems.
   
• For instance, as per the National Institute of Mental Health (NIMH), Generalized Anxiety Disorder (GAD) affects 6.8 million adults or 3.1% of the U.S. population, with women being twice as likely to be affected as men. Similarly, Social Anxiety Disorder (SAD) affects 15 million adults or 7.1% of the U.S. population.
   
• Additionally, high prevalence of anxiety disorder in geriatric population further drives the market growth. For instance, as per the World Health Organization (WHO), around 14% of adults aged 60 and over live with a mental disorder, with depression and anxiety being the most common conditions among older adults globally.
   
• Thus, as the global population ages and the prevalence of anxiety disorders in older adults continues to rise, the demand for benzodiazepine drugs is expected to increase, driving growth in the market.